$IMMB .213 Breaking News: Video Interview With Harry Zhabilov of Immunotech Laboratories Inc.

HUNTINGTON BEACH, Calif., Feb. 12, 2013 /PRNewswire via COMTEX/ -- Recently, Immunotech Laboratories (IMMB) President Harry Zhabilov and Director Bo Linton welcomed UndiscoveredCompanies.com into their facilities to conduct an interview.

Part I of the video series was released earlier this month featuring newly appointed Director Bo Linton. In Part II, we discuss the company, its goals, and treatments with the founder, President Harry Zhabilov.

Topics discussed with Harry Zhabilov include the addition of new board members, goals of up-listing to NASDAQ, the FDA, and how the immunotherapy treatment works.

The newly released Part II can be viewed at http://youtu.be/oPFso7SiCYs

For those whom have not seen it yet, the first part featuring Company Director Mr. Bo Linton can be viewed at http://www.youtube.com/watch?v=uCjNAf30aeo

About Immunotech LaboratoriesImmunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases such as HIV, Cancer, Hepatitis and AIDS. Immunotech is committed to creating drugs for the better health of mankind.

About Undiscovered CompaniesUndiscovered Companies is a video news provider of public and private companies looking for new marketing ideas and product exposure.